Who Paid My Doc
A 52-Week, Randomised, Double-Blind, Double-Dummy, Parallel Group, Mul
Research payments
$14,078,174
Through program year 2025, $14,078,174 in research payments was reported against A 52-Week, Randomised, Double-Blind, Double-Dummy, Parallel Group, Mul, across 3,806 payments, paid by GlaxoSmithKline, LLC..
- Paid by
- GlaxoSmithKline, LLC.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $1,677,288 | 772 |
| 2024 | Research | $4,039,135 | 979 |
| 2023 | Research | $3,330,358 | 931 |
| 2022 | Research | $3,206,073 | 840 |
| 2021 | Research | $1,825,320 | 284 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Amit Patel Riverside, CA Named on 41 payments
- Jonathan Ilowite New Hyde Park, NY Named on 38 payments
- Christine Vidouria San Antonio, TX Named on 35 payments
- Alberto Manzor Pembroke Pines, FL Named on 34 payments
- Lee Clore Owensboro, KY Named on 34 payments
- Geoffrey Chupp Darien, CT Named on 34 payments
- Bruce Decotiis Wall Township, NJ Named on 33 payments
- Michael Manning Gilbert, AZ Named on 33 payments
- David Bernstein Cincinnati, OH Named on 32 payments
- Jaime Landman Fort Lauderdale, FL Named on 31 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.